Surescripts Contemplates Sale Amid Neutrality Concerns
Tuesday, 2 April 2024, 15:38
Surescripts Contemplates Sale
Surescripts, a prominent electronic prescribing company, is actively considering a sale to safeguard its neutrality in the industry. Owned by CVS Health and Cigna's Express Scripts, the company is exploring this strategic move to avoid potential conflicts of interest and uphold fair market practices. The decision to sell could reshape the landscape of healthcare technology and prescription management in the near future.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.